In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid beta-peptide (1-42).
Butterfield
D A
DA
Department of Chemistry, University of Kentucky, Lexington 40506, USA. dabcns@pop.uky.edu
Yatin
S M
SM
Link
C D
CD
D000544:Alzheimer Disease / Q000473:pathology / Q000503:physiopathology*; D016229:Amyloid beta-Peptides / Q000494:pharmacology / Q000502:physiology*; D001921:Brain / Q000378:metabolism*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D006801:Humans; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009498:Neurotoxins / Q000494:pharmacology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010446:Peptide Fragments / Q000494:pharmacology / Q000502:physiology*; D017382:Reactive Oxygen Species
D016229:Amyloid beta-Peptides; D009498:Neurotoxins; D010446:Peptide Fragments; D017382:Reactive Oxygen Species; C075222:amyloid beta-protein (1-42)